Mitsubishi Tanabe Pharma（4508）

Issuer Code Long Term Short Term
Mitsubishi Tanabe Pharma 4508 - -

News ReleaseMore

Oct. 30, 2020
JCR Withdraws A+p/Stable Long-term Issuer Rating on Mitsubishi Tanabe PharmaMember Only
Jun. 17, 2020
Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2020Member Only
Nov. 19, 2019
Mitsubishi Chemical Holdings’ Making Mitsubishi Tanabe Pharma a Wholly-owned Subsidiary - JCR will Pay Attention to Improvement of Financial Structure and Synergistic EffectsMember Only
Sep. 11, 2019
JCR Affirmed A+p/Stable Long-term Issuer Rating on Mitsubishi Tanabe PharmaMember Only
Jun. 25, 2019
Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2019Member Only
Apr. 24, 2018
JCR Affirmed A+p/Stable Long-term Issuer Rating on Mitsubishi Tanabe PharmaMember Only
May. 26, 2017
JCR Affirmed A+p/Stable on Mitsubishi Tanabe PharmaMember Only
Mar. 16, 2016
JCR Affirmed A+p/Stable on Mitsubishi Tanabe PharmaMember Only
Jan. 27, 2015
JCR Affirmed A+p/Stable Long-term Issuer Rating on Mitsubishi Tanabe PharmaMember Only
Feb. 13, 2014
JCR Affirmed A+p/Stable Long-term Issuer Rating on Mitsubishi Tanabe PharmaMember Only

Issuer ReportsMore

ESG Credit OutlookMore

Reports relating to IssuerMore

Rating Lists
Corporates
Financial Institutions
Public Sector
Structured Finance (Investment Corporations)
Structured Finance (Structured Finance Products)
Sovereigns and Supranationals